Tempus AI, Inc. (NASDAQ:TEM) Receives Consensus Rating of “Hold” from Brokerages

Shares of Tempus AI, Inc. (NASDAQ:TEM) have been given an average recommendation of “Hold” by the fifteen brokerages that are covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and nine have issued a buy rating on the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $68.6429.

A number of research analysts have recently issued reports on TEM shares. Mizuho started coverage on Tempus AI in a research note on Thursday, February 19th. They set an “outperform” rating and a $100.00 price objective on the stock. JPMorgan Chase & Co. reduced their price objective on Tempus AI from $80.00 to $60.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 25th. Jefferies Financial Group assumed coverage on shares of Tempus AI in a report on Monday, April 13th. They set an “underperform” rating and a $35.00 target price for the company. HC Wainwright dropped their target price on shares of Tempus AI from $95.00 to $64.00 and set a “buy” rating for the company in a report on Monday, May 11th. Finally, Guggenheim dropped their target price on shares of Tempus AI from $95.00 to $60.00 and set a “buy” rating for the company in a report on Monday, March 30th.

Insider Activity at Tempus AI

In other news, CAO Ryan M. Bartolucci sold 4,116 shares of the stock in a transaction dated Tuesday, May 19th. The shares were sold at an average price of $44.07, for a total transaction of $181,392.12. Following the completion of the sale, the chief accounting officer directly owned 74,041 shares in the company, valued at approximately $3,262,986.87. This represents a 5.27% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO James William Rogers sold 10,853 shares of the stock in a transaction dated Tuesday, May 19th. The stock was sold at an average price of $44.07, for a total transaction of $478,291.71. Following the sale, the chief financial officer owned 126,395 shares of the company’s stock, valued at approximately $5,570,227.65. This represents a 7.91% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 558,557 shares of company stock valued at $26,611,939 in the last quarter. 24.26% of the stock is currently owned by company insiders.

Institutional Trading of Tempus AI

A number of institutional investors have recently modified their holdings of TEM. JPL Wealth Management LLC purchased a new stake in shares of Tempus AI during the third quarter worth about $26,000. Los Angeles Capital Management LLC purchased a new stake in shares of Tempus AI during the fourth quarter worth about $27,000. Harvest Fund Management Co. Ltd purchased a new stake in shares of Tempus AI during the third quarter worth about $38,000. Whittier Trust Co. boosted its holdings in shares of Tempus AI by 190.0% during the first quarter. Whittier Trust Co. now owns 870 shares of the company’s stock worth $41,000 after purchasing an additional 570 shares during the period. Finally, Lodestone Wealth Management LLC purchased a new stake in shares of Tempus AI during the fourth quarter worth about $42,000. 24.22% of the stock is currently owned by hedge funds and other institutional investors.

Tempus AI Stock Down 3.6%

Shares of NASDAQ:TEM opened at $47.82 on Tuesday. The stock’s 50-day moving average price is $49.32 and its 200-day moving average price is $56.82. Tempus AI has a 12-month low of $41.73 and a 12-month high of $104.32. The stock has a market capitalization of $8.59 billion, a P/E ratio of -27.80 and a beta of 3.62. The company has a current ratio of 3.31, a quick ratio of 3.15 and a debt-to-equity ratio of 2.96.

Tempus AI (NASDAQ:TEM) last announced its quarterly earnings data on Tuesday, May 5th. The company reported ($0.13) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.21) by $0.08. Tempus AI had a negative return on equity of 53.83% and a negative net margin of 22.20%.The firm had revenue of $348.12 million for the quarter, compared to analysts’ expectations of $345.44 million. During the same period last year, the firm earned ($0.24) earnings per share. The company’s revenue for the quarter was up 36.1% compared to the same quarter last year. On average, equities analysts anticipate that Tempus AI will post -1.35 earnings per share for the current year.

Tempus AI Company Profile

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.